SAN DIEGO, May 30, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results